Brazil to test new vaccine against dengue fever

September 26, 2013

Brazilian scientists will next month begin clinical tests on humans of a new vaccine against dengue fever, a leading Sao Paulo-based biomedical research institute said Thursday.

The is being developed to combat the four closely related strains of dengue viruses that have been identified around the world, the Butantan institute said in a statement.

Brazil is frequently afflicted with the disease, which is spread by the mosquito Aedes aegypti.

Work on the vaccine began in 2005 in partnership with the US National Institutes of Health (NIH), Butantan said.

In a first phase, the vaccine was tested on animals and humans in the United States and produced a good immunological response, it noted.

The second phase is to begin in October with on 300 Brazilian volunteers, all healthy adults aged between 18 and 59 of both sexes, over a five-year period.

The institute said the vaccine is expected to be ready by 2018.

"This new phase is very important because it will be adapted to the particular characteristics of the Brazilian population," said Butantan Director Jorge Kalil.

"The production of a Brazilian vaccine for is a major advance for public health," said Sao Paulo state Giovanni Guido Cerri.

"We are making major strides toward producing a safe, effective and low-cost vaccine which can be incorporated into the National Immunization Program and meet the entire Brazilian demand."

Dengue fever affects between 50 and 100 million people in the tropics and subtropics each year, causing fever, muscle and joint ache as well as potentially fatal dengue hemorrhagic fever and dengue shock syndrome.

Researchers estimate that around three billion people in the world live in regions susceptible to dengue contagion and another 20 million tourists pass through them.

Butantan, which has a long tradition of research on snakes and poisonous animals, is the leading domestic producer of anti-venom sera and vaccines.

Explore further: Brazil to breed GM mosquitoes to combat dengue

Related Stories

Brazil to breed GM mosquitoes to combat dengue

July 10, 2012
Brazil said Monday it will breed huge numbers of genetically modified mosquitoes to help stop the spread of dengue fever, an illness that has already struck nearly 500,000 people this year nationwide.

Brazilian scientists to test AIDS vaccine on monkeys

August 6, 2013
Brazilian scientists have developed an HIV vaccine and plan to begin testing on monkeys later this year, a sponsor institution said Monday.

Dengue fever outbreak hits Costa Rica

April 10, 2013
Health officials in Costa Rica said an outbreak of dengue fever has sickened 7,000 people, with many cases occurring in some of this Central American country's most popular tourist areas.

Dengue raises alarm in Central America

July 3, 2013
Authorities have issued dengue alerts in four nations across Central America, where alarm is rising as the mosquito-borne disease has infected 30,000 people and killed 17 this year alone.

Concerns over cost of dengue vaccine lessened with new study

June 28, 2012
Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million ...

Dengue outbreak has killed 26 in Central America: officials

July 25, 2013
An unusually potent outbreak of dengue fever has killed 26 people and infected nearly 40,000 more so far this year in Central America, where the mosquito-born illness is endemic.

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.